Stephen Schleicher, MD, became the organization’s CMO on Jan. 1. He succeeded Natalie Dickson, MD, who will remain in her role as president of the company while taking on the newly created role of chief strategy officer, a Jan. 3 news release said.
As CMO, Dr. Dickson helped facilitate Tennessee Oncology’s entrance into Medicare’s Oncology Care Model. Her other achievements include the launch of integrative oncology and genetics counseling programs and the creation of one of oncology’s largest internal palliative care programs, the news release said.
Dr. Schleicher joined Tennessee Oncology three years ago, most recently serving as the medical director of value-based care. He is also the president of the Tennessee Oncology Practice Society.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.